PTGS2 and neoplasm: Inhibition of COX-2, especially through nonsteroidal anti-inflammatory drugs (NSAIDs), has been considered a therapeutic alternative for arresting tumor growth (Gupta and Dubois, 2001; Ulrich et al., 2006).